Another Huge Buffett Purchase Highlights Recent Insider Buying
Another huge Warren Buffett purchase highlighted the past week's insider buying, and a couple of IPOs also prompted insiders to action.
Astria Therapeutics, Inc. is a Boston-based biopharmaceutical firm dedicated to developing treatments for rare and specialized allergic and immunological diseases. Its flagship project, STAR-0215, is a pioneering monoclonal antibody aimed at treating hereditary angioedema, currently in the clinical trial phase. Originally known as Catabasis Pharmaceuticals, Astria rebranded in 2021, continuing its mission since its inception in 2008 to address unmet medical needs in niche disease areas.
Another huge Warren Buffett purchase highlighted the past week's insider buying, and a couple of IPOs also prompted insiders to action.
As the year wound to a close, the most notable insider buying was focused on biotech stocks, but an oil and gas company CEO also returned to the buy window.